Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
66M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
17.4M
-
Shares change
-
-581K
-
Total reported value, excl. options
-
$23.4M
-
Value change
-
-$2.41M
-
Put/Call ratio
-
6.83
-
Number of buys
-
15
-
Number of sells
-
-42
-
Price
-
$1.35
Significant Holders of Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) as of Q3 2023
72 filings reported holding STIM - Neuronetics, Inc. - Common Stock, par value $0.01 per share as of Q3 2023.
Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.4M shares
of 66M outstanding shares and own 26.29% of the company stock.
Largest 10 shareholders include Archon Capital Management LLC (2.88M shares), CANNELL CAPITAL LLC (2.83M shares), Kent Lake Capital LLC (2.33M shares), Balyasny Asset Management L.P. (1.4M shares), VANGUARD GROUP INC (1.35M shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (1.13M shares), First Eagle Investment Management, LLC (776K shares), First Washington CORP (511K shares), BlackRock Inc. (381K shares), and ACADIAN ASSET MANAGEMENT LLC (370K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.